EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment.
about
World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patientsPhytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical PathologyNew insights in IBS-like disorders: Pandora's box has been opened; a reviewIn vivo Technique for Cellular Calcium Waves Documentation: A Light Microscopy Method.New developments and controversies in iron metabolism and iron chelation therapy.Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor.The application of EDTA in drug delivery systems: doxorubicin liposomes loaded via NH4EDTA gradient.The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum.Safety and efficacy of topical bacteriophage and ethylenediaminetetraacetic acid treatment of Staphylococcus aureus infection in a sheep model of sinusitis.Chelation therapy: overlooked in the treatment and prevention of diabetes complications?Activation of Alkaline Irrigation Fluids in Endodontics.Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function.
P2860
Q26826936-54E8E040-C977-4679-A083-8B14F882321AQ26863390-2DD78332-94E8-4380-88CF-B30C777161CFQ33867365-F2BD5ED9-7FAF-4A95-AA06-A21DBD48F62DQ34982850-D38829F2-DB66-43EA-8980-DC62E782289EQ36719376-09B0DB7F-DF15-4392-B263-E8A694B99141Q37272142-2283206A-C738-4A86-A9B3-5EABDACC2386Q38966370-1B00E56F-066D-447A-B2C3-6EBD484AB2FFQ41660396-FB9CA8CB-5210-442B-8AC8-2797C50D4614Q42241966-A2224FBD-FB05-4137-8E44-4D637348E861Q46211806-C14C2EC0-B667-4F29-BECF-AE2A63F34D80Q47099170-7814299C-43BB-40C9-BD05-FEC9DF43650AQ48510488-C1CD730C-2F8A-41F6-88E7-5466A21B33A9
P2860
EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
EDTA chelation reappraisal fol ...... s and risk/benefit assessment.
@ast
EDTA chelation reappraisal fol ...... s and risk/benefit assessment.
@en
EDTA chelation reappraisal fol ...... s and risk/benefit assessment.
@nl
type
label
EDTA chelation reappraisal fol ...... s and risk/benefit assessment.
@ast
EDTA chelation reappraisal fol ...... s and risk/benefit assessment.
@en
EDTA chelation reappraisal fol ...... s and risk/benefit assessment.
@nl
prefLabel
EDTA chelation reappraisal fol ...... s and risk/benefit assessment.
@ast
EDTA chelation reappraisal fol ...... s and risk/benefit assessment.
@en
EDTA chelation reappraisal fol ...... s and risk/benefit assessment.
@nl
P2093
P2860
P1476
EDTA chelation reappraisal fol ...... s and risk/benefit assessment.
@en
P2093
Annita Kolnagou
Aspasia Spyrou
Christina N Kontoghiorghe
George J Kontoghiorghes
Tammy Born
P2860
P356
10.3109/15376516.2012.730562
P577
2012-10-19T00:00:00Z